Squarepoint
ADPT icon

Squarepoint’s Adaptive Biotechnologies ADPT Stock Holding History

Squarepoint’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.21M Sell
102,897
-19,089
-16% -$292K ﹤0.01% 2262
2026
Q1 		$1.69M Buy
121,986
+52,251
+75% +$832K ﹤0.01% 2321
2025
Q4 		$1.13M Sell
69,735
-121,374
-64% -$1.98M ﹤0.01% 2498
2025
Q3 		$2.86M Sell
191,109
-26,842
-12% -$327K ﹤0.01% 1823
2025
Q2 		$2.54M Buy
217,951
+150,963
+225% +$1.37M ﹤0.01% 1918
2025
Q1 		$498K Buy
66,988
+22,587
+51% +$174K ﹤0.01% 3306
2024
Q4 		$266K Buy
44,401
+32,247
+265% +$178K ﹤0.01% 4244
2024
Q3 		$62.2K Buy
+12,154
New +$53K ﹤0.01% 3956
2024
Q1 		– Sell
-75,659
Closed -$371K – 3949
2023
Q4 		$371K Buy
+75,659
New +$345K ﹤0.01% 3220
2023
Q3 		– Sell
-31,637
Closed -$212K – 3731
2023
Q2 		$212K Buy
+31,637
New +$235K ﹤0.01% 3189
2023
Q1 		– Sell
-50,889
Closed -$389K – 3171
2022
Q4 		$389K Sell
50,889
-92,118
-64% -$717K ﹤0.01% 2432
2022
Q3 		$1.02M Buy
+143,007
New +$1.35M 0.01% 1761
2022
Q2 		– Sell
-57,432
Closed -$797K – 2829
2022
Q1 		$797K Buy
+57,432
New +$903K ﹤0.01% 1720
2021
Q2 		– Sell
-41,956
Closed -$1.69M – 3173
2021
Q1 		$1.69M Buy
+41,956
New +$2.27M 0.01% 1162
2019
Q4 		– Sell
-10,910
Closed -$337K – 2448
2019
Q3 		$337K Buy
+10,910
New +$445K ﹤0.01% 1838

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Squarepoint's ADPT Position: Q2 2026 in Review

Squarepoint reduced its Adaptive Biotechnologies (ADPT) stake by 16% in Q2 2026, selling an estimated $292K and leaving 102,897 shares worth $2.21M. The position accounts for ﹤0.01% of the portfolio, ranked #2262.

Squarepoint first reported a position in ADPT in Q3 2019 and has held it in 15 quarters since. The position peaked at $2.86M in Q3 2025. 301 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Squarepoint held 102,897 shares of Adaptive Biotechnologies worth $2.21M as of Q2 2026.
  • Squarepoint sold 19,089 Adaptive Biotechnologies shares in Q2 2026, an estimated $292K.
  • Adaptive Biotechnologies made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #2262 holding.
  • Squarepoint first reported a position in Adaptive Biotechnologies in Q3 2019 and has held it in 15 quarters since.
  • Squarepoint's Adaptive Biotechnologies position peaked at $2.86M in Q3 2025.
  • 301 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.